Plasma p-tau181/Aβ
Alzheimer's disease
amyloid beta amyloid imaging
blood biomarkers
blood diagnostic for Alzheimer's disease
cerebrospinal fluid
phosphorylated tau
plasma amyloid beta
plasma phosphorylated tau181
positron emission tomography
Journal
Alzheimer's & dementia (Amsterdam, Netherlands)
ISSN: 2352-8729
Titre abrégé: Alzheimers Dement (Amst)
Pays: United States
ID NLM: 101654604
Informations de publication
Date de publication:
2022
2022
Historique:
received:
18
09
2022
accepted:
28
09
2022
entrez:
30
11
2022
pubmed:
1
12
2022
medline:
1
12
2022
Statut:
epublish
Résumé
In Alzheimer's disease (AD), plasma amyloid beta (Aβ) Prototype Simoa assays were used to measure plasma samples from participants who were either cognitively normal (CN) or had mild cognitive impairment (MCI)/AD in the Australian Imaging, Biomarkers and Lifestyle (AIBL) study. The p-tau181/Aβ Plasma p-tau181/Aβ
Sections du résumé
Background
UNASSIGNED
In Alzheimer's disease (AD), plasma amyloid beta (Aβ)
Methods
UNASSIGNED
Prototype Simoa assays were used to measure plasma samples from participants who were either cognitively normal (CN) or had mild cognitive impairment (MCI)/AD in the Australian Imaging, Biomarkers and Lifestyle (AIBL) study.
Results
UNASSIGNED
The p-tau181/Aβ
Discussion
UNASSIGNED
Plasma p-tau181/Aβ
Identifiants
pubmed: 36447478
doi: 10.1002/dad2.12375
pii: DAD212375
pmc: PMC9695763
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e12375Informations de copyright
© 2022 The Authors. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring published by Wiley Periodicals, LLC on behalf of Alzheimer's Association.
Déclaration de conflit d'intérêts
Eugeen Vanmechelen is cofounder and shareholder of ADx NeuroSciences. Erik Stoops is employee and shareholder of ADx NeuroSciences. Jeroen Vanbrabant, Nele Dewit, and Kimberley Mauroo are employees of ADx NeuroSciences. Paul Maruff is a full‐time employee of Cogstate Ltd. Christopher C. Rowe has received research grants from NHMRC, Enigma Australia, Biogen, Eisai, and Abbvie; he is on the scientific advisory board for Cerveau Technologies; and consulted for Prothena, Eisai, Roche, and Biogen Australia. The other authors did not report any conflict of interest. Author disclosures are available in the supporting information
Références
J Neurol Neurosurg Psychiatry. 2021 Nov;92(11):1231-1241
pubmed: 34510001
Alzheimers Dement (Amst). 2017 Jul 01;9:25-34
pubmed: 28795133
Alzheimers Dement. 2019 Feb;15(2):205-216
pubmed: 30347188
Alzheimers Res Ther. 2020 Dec 5;12(1):162
pubmed: 33278904
Alzheimers Res Ther. 2020 Mar 4;12(1):22
pubmed: 32131891
Nat Neurosci. 2020 Oct;23(10):1183-1193
pubmed: 32778792
Biol Psychiatry. 2014 May 1;75(9):723-31
pubmed: 24548642
Brain. 2017 May 1;140(5):1486-1498
pubmed: 28383676
Alzheimers Res Ther. 2021 Dec 4;13(1):198
pubmed: 34863295
Lancet Neurol. 2016 Sep;15(10):1044-53
pubmed: 27450471
Neuroimage. 2018 Dec;183:387-393
pubmed: 30130643
Clin Chem. 2021 Nov 26;67(12):1628-1639
pubmed: 34662373
Nature. 2018 Feb 8;554(7691):249-254
pubmed: 29420472
J Nucl Med. 2016 Aug;57(8):1233-7
pubmed: 26912446
J Nucl Med. 2013 Jun;54(6):880-6
pubmed: 23575995
Alzheimers Res Ther. 2018 Jul 31;10(1):74
pubmed: 30064520
Sci Rep. 2019 Dec 13;9(1):19024
pubmed: 31836810
Semin Nucl Med. 2021 May;51(3):241-252
pubmed: 33482999
Neurology. 2019 Oct 22;93(17):e1647-e1659
pubmed: 31371569
Acta Neuropathol. 2021 May;141(5):709-724
pubmed: 33585983
Alzheimers Dement. 2018 Apr;14(4):535-562
pubmed: 29653606
J Exp Med. 2020 Nov 2;217(11):
pubmed: 32725127
Alzheimers Dement (Amst). 2021 May 01;13(1):e12182
pubmed: 33969174
Alzheimers Dement. 2015 Jan;11(1):1-15.e1-4
pubmed: 25443857
Alzheimers Dement (Amst). 2021 May 18;13(1):e12190
pubmed: 34027020
Clin Biochem. 2019 Oct;72:30-38
pubmed: 31129184
Alzheimers Dement. 2021 Oct;17(10):1649-1662
pubmed: 33792168
Alzheimers Dement. 2022 Apr;18(4):635-644
pubmed: 34310035
J Clin Exp Neuropsychol. 2019 Aug;41(6):591-600
pubmed: 30924399
J Alzheimers Dis Rep. 2021 Jun 03;5(1):443-468
pubmed: 34368630
Nat Med. 2020 Mar;26(3):387-397
pubmed: 32123386
Sci Rep. 2021 May 6;11(1):9736
pubmed: 33958661
Lancet Neurol. 2015 Jan;14(1):114-24
pubmed: 25496902
Alzheimers Res Ther. 2020 Mar 31;12(1):36
pubmed: 32234072
Lancet Neurol. 2020 May;19(5):422-433
pubmed: 32333900
Ann Neurol. 2018 Nov;84(5):648-658
pubmed: 30196548
Clin Chem. 2001 Oct;47(10):1776-81
pubmed: 11568086
EMBO Mol Med. 2021 Aug 9;13(8):e14398
pubmed: 34254442
Neurology. 2016 Aug 2;87(5):539-47
pubmed: 27371494